Researchers at MIT and Brigham and Women's Hospital have developed a new drug capsule that remains in the stomach for up to two weeks after being swallowed, gradually releasing its drug payload. This type of drug delivery could potentially assist in eliminating diseases such as malaria.

Previous articlePrecision Immuno-Oncology Adoption Challenges
Next articlePluristem, NYBC Win $900K to Test PLX-R18 Cells Alongside Cord Blood Transplants